Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane 4 L6 family member 5 (TM4SF5) is a cell-surface glycoprotein belonging to the transmembrane 4 L6 family, which is closely related to the tetraspanin family. It features four transmembrane domains and two extracellular loops, forming tetraspanin-enriched microdomains (TERMs) that act as signaling hubs on the cell membrane. TM4SF5 plays a critical role in regulating cell proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT) by interacting with integrins, growth factor receptors (such as EGFR), and cytosolic signaling molecules like focal adhesion kinase (FAK) and c-Src. Additionally, TM4SF5 acts as a lysosomal membrane arginine sensor, regulating mTORC1 signaling and hepatocyte nutrient metabolism. TM4SF5 is aberrantly overexpressed in various malignancies, including hepatocellular carcinoma, colorectal cancer, pancreatic cancer, and esophageal cancer, where it promotes tumor progression, metastasis, and drug resistance. It is also implicated in chronic liver diseases such as nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), and liver fibrosis. Consequently, TM4SF5 is a promising therapeutic target, with several monoclonal antibodies, antibody-drug conjugates (such as BCG015), and small-molecule inhibitors (such as TSAHC and RCT-1213) under preclinical development to neutralize its activity and suppress tumor growth.
Inhibition of TM4SF5-mediated signaling, neutralization of TM4SF5, antibody-dependent cellular cytotoxicity (ADCC), or antibody-drug conjugate (ADC) mediated cytotoxicity.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane 4 L6 family member 5 (TM4SF5).